BHP Petroleum, Woodside Merger On Track; Details Proposed In Specie Dividend Of Woodside Shares

BHP Group Limited (BHP.AX,BLT.L,BBL,BHP) issued an update on BHP Petroleum and Woodside (WOPEF.PK,WOPEY.PK,WPL.AX) merger. The completion of the merger is on track and is targeted for 1 June 2022. All required regulatory and competition approvals have been obtained, other than the National Offshore Petroleum Titles Administrator or NOPTA approval.

BHP is expected to receive 914.8 million newly issued Woodside shares at completion. BHP shareholders are expected to be entitled to one Woodside share for every 5.5340 BHP shares. The company will determine a fully franked in specie dividend of the Woodside shares to BHP shareholders. The in specie dividend would be $4.62 with $1.98 of franking credits being distributed per BHP share, based on Woodside's share price of $25.55 at 6 April 2022. The dividend is expected to be paid on 1 June 2022 to each BHP shareholder on the BHP register at the close of business on 26 May 2022.

On completion, Woodside will make a cash payment to BHP of approximately $830 million in relation to cash dividends paid by Woodside. BHP will make a cash payment to Woodside for the net cash flow generated by BHP Petroleum between the merger effective date of 1 July 2021 and completion. From the effective date to 31 December 2021 only, this amounts to approximately $900 million.

Woodside has released an Independent Expert's Report for shareholders, which has concluded that the merger is in the best interests of Woodside shareholders, in the absence of a superior proposal. The Woodside shareholder meeting is scheduled for 19 May 2022.

Woodside will retain its primary listing on the ASX and is seeking a standard listing on the LSE and a sponsored Level III ADR program on the NYSE.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon has unveiled millions of deals worldwide that will be available during its upcoming Prime Day extravaganza. The 48-hour shopping event for Prime members kicks off July 12 at 3 a.m. EDT, offering deals of up to 79% off across various categories. These include electronics, devices, toys, beauty, fashion, and home, from top national brands and small businesses. Primal Pet Foods is recalling a single lot of Raw Frozen Primal Patties for Dogs Beef Formula due to potential contamination with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves lot #W10068709 of 6-pound Raw Frozen Primal Patties with best by date of 05/22/23. The Raw Frozen Primal Patties are sold in flexible packaging in the freezer at select pet stores. The U.S. Food and Drug Administration has authorized state-licensed pharmacists to prescribe COVID-19 pill Paxlovid (nirmatrelvir and ritonavir) by drug major Pfizer Inc. to eligible patients, with certain limitations. The agency has revised the Emergency Use Authorization or EUA for Paxlovid for the authorization, which could improve access for some patients at high risk for severe covid-19.
Follow RTT